Literature DB >> 23816392

Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: a model to study intervention strategies.

J H C M Kreijtz1, E J B Veldhuis Kroeze, K J Stittelaar, L de Waal, G van Amerongen, S van Trierum, P van Run, T Bestebroer, R A M Fouchier, G F Rimmelzwaan, A D M E Osterhaus.   

Abstract

Infections with low pathogenic avian influenza (LPAI) A(H7N9) viruses have caused more than 100 hospitalized human cases of severe influenza in China since February 2013 with a case fatality rate exceeding 25%. Most of these human infections presented with severe viral pneumonia, while limited information is available currently on the occurrence of mild and subclinical cases. In the present study, a ferret model for this virus infection in humans is presented to evaluate the pathogenesis of the infection in a mammalian host, as ferrets have been shown to mimic the pathogenesis of human infection with influenza viruses most closely. Ferrets were inoculated intratracheally with increasing doses (>10 e5 TCID50) of H7N9 influenza virus A/Anhui/1/2013 and were monitored for clinical and virological parameters up to four days post infection. Virus replication was detected in the upper and lower respiratory tracts while animals developed fatal viral pneumonia. This study illustrates the high pathogenicity of LPAI-H7N9 virus for mammals. Furthermore, the intratracheal inoculation route in ferrets proofs to offer a solid model for LPAI-H7N9 virus induced pneumonia in humans. This model will facilitate the development and assessment of clinical intervention strategies for LPAI-H7N9 virus infection in humans, such as preventive vaccination and the use of antivirals.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Avian influenza A; H7N9; Intervention strategies

Mesh:

Year:  2013        PMID: 23816392     DOI: 10.1016/j.vaccine.2013.06.071

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  29 in total

1.  H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets.

Authors:  Jørgen de Jonge; Harry van Dijken; Femke de Heij; Sanne Spijkers; Justin Mouthaan; Rineke de Jong; Paul Roholl; Eduardo Alfredo Adami; Milena Apetito Akamatsu; Paulo Lee Ho; Livia Brunner; Nicolas Collin; Martin Friede; José A Ferreira; Willem Luytjes
Journal:  NPJ Vaccines       Date:  2020-05-11       Impact factor: 7.344

2.  Novel avian-origin influenza A (H7N9) virus attachment to the respiratory tract of five animal models.

Authors:  Jurre Y Siegers; Kirsty R Short; Lonneke M E Leijten; Miranda de Graaf; Monique I J Spronken; Eefje J A Schrauwen; Nicolle Marshall; Anice C Lowen; Gülsah Gabriel; Albert D M E Osterhaus; Thijs Kuiken; Debby van Riel
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

3.  Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.

Authors:  Carolien E van de Sandt; Joost H C M Kreijtz; Gerrie de Mutsert; Martina M Geelhoed-Mieras; Marine L B Hillaire; Stella E Vogelzang-van Trierum; Albert D M E Osterhaus; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

4.  Influenza A Virus Reassortment Is Limited by Anatomical Compartmentalization following Coinfection via Distinct Routes.

Authors:  Mathilde Richard; Sander Herfst; Hui Tao; Nathan T Jacobs; Anice C Lowen
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

Review 5.  Mammalian models for the study of H7 virus pathogenesis and transmission.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

6.  H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.

Authors:  Jørgen de Jonge; Irina Isakova-Sivak; Harry van Dijken; Sanne Spijkers; Justin Mouthaan; Rineke de Jong; Tatiana Smolonogina; Paul Roholl; Larisa Rudenko
Journal:  Mol Ther       Date:  2016-01-22       Impact factor: 11.454

7.  A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model.

Authors:  Joost H C M Kreijtz; Lidewij C M Wiersma; Heidi L M De Gruyter; Stella E Vogelzang-van Trierum; Geert van Amerongen; Koert J Stittelaar; Ron A M Fouchier; Albert D M E Osterhaus; Gerd Sutter; Guus F Rimmelzwaan
Journal:  J Infect Dis       Date:  2014-09-22       Impact factor: 5.226

8.  Detection of nonhemagglutinating influenza a(h3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus culture.

Authors:  C A van Baalen; C Els; L Sprong; R van Beek; E van der Vries; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

Review 9.  Role of receptor binding specificity in influenza A virus transmission and pathogenesis.

Authors:  Miranda de Graaf; Ron A M Fouchier
Journal:  EMBO J       Date:  2014-03-25       Impact factor: 11.598

10.  Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig model.

Authors:  Jon D Gabbard; Daniel Dlugolenski; Debby Van Riel; Nicolle Marshall; Summer E Galloway; Elizabeth W Howerth; Patricia J Campbell; Cheryl Jones; Scott Johnson; Lauren Byrd-Leotis; David A Steinhauer; Thijs Kuiken; S Mark Tompkins; Ralph Tripp; Anice C Lowen; John Steel
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.